药石科技(300725) - 2018 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders rose by 95.56% to CNY 40,858,735.41 for the reporting period[8] - Operating revenue for the period reached CNY 128,323,860.88, reflecting a growth of 73.91% year-on-year[8] - Basic earnings per share increased by 46.68% to CNY 0.3714[8] - The net profit after deducting non-recurring gains and losses was CNY 37,702,464.57, an increase of 89.44% year-on-year[8] - The company reported a net profit increase, leading to an increase in undistributed profits by 105.80% to ¥154,345,172.88[16] - The net profit for the third quarter reached CNY 40,858,735.41, up from CNY 21,012,436.89 in the same period last year, representing an increase of approximately 94.5%[36] - The total profit for the third quarter was CNY 46,963,399.24, compared to CNY 26,143,107.62 in the previous year, reflecting an increase of approximately 79.5%[35] - The company's total profit for Q3 2018 was CNY 107,891,639.02, compared to CNY 61,839,115.99 in the same period last year, reflecting a growth of 74.5%[43] Revenue and Costs - Total operating revenue for Q3 2018 reached CNY 128,323,860.88, a significant increase of 73.8% compared to CNY 73,787,398.47 in the same period last year[33] - Total operating costs for the same period were CNY 85,098,192.60, up from CNY 49,271,525.06, reflecting a year-over-year increase of 72.7%[33] - The total operating revenue for the third quarter was CNY 149,508,564.47, compared to CNY 72,929,325.72 in the previous period, indicating a significant increase[38] - The total operating costs for the third quarter were CNY 83,515,793.76, compared to CNY 28,909,918.68 in the previous year, indicating a significant rise[38] Assets and Liabilities - Total assets increased by 14.84% to CNY 651,575,267.59 compared to the end of the previous year[8] - The company's total assets increased to CNY 681,228,045.08, up from CNY 563,909,540.12, representing a growth of 20.8%[32] - Total liabilities rose to CNY 94,534,022.40, compared to CNY 57,958,438.41, indicating an increase of 63.1%[32] - The equity attributable to shareholders reached CNY 586,694,022.68, up from CNY 505,951,101.71, marking an increase of 15.9%[32] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 89,145,846.49, up 75.17%[8] - Cash inflow from operating activities totaled CNY 371,560,529.60 in Q3 2018, compared to 219,724,473.55 in the previous year, representing a growth of 68.8%[48] - The cash inflow from sales of goods and services was 331,550,514.61, up from 193,592,384.44 in the previous period, representing an increase of approximately 71%[53] - The cash outflow from financing activities amounted to 23,983,622.36, compared to 4,028,304.30 in the previous period, indicating a substantial increase[54] Research and Development - Research and development expenses increased by 71.27% to ¥28,463,244.49, indicating a significant investment in innovation[17] - Research and development expenses for the quarter amounted to CNY 10,166,612.14, which is an increase of 74.1% compared to CNY 5,836,844.66 in the previous year[33] - Research and development expenses for Q3 2018 amounted to CNY 23,889,234.82, up from CNY 13,049,294.93 in the previous year, indicating a 83.5% increase[46] Shareholder Information - The company reported a total of 10,275 common shareholders at the end of the reporting period[12] - The top shareholder, Yang Minmin, holds 22.22% of the shares, amounting to 24,442,023 shares[12] Tax and Other Financial Metrics - The tax payable increased by 220.37% to ¥10,047,968.73, reflecting higher profits and corresponding tax liabilities[16] - The company reported a tax expense of CNY 12,741,028.34 for Q3 2018, compared to CNY 9,059,364.75 in the previous year, which is an increase of 40.5%[43] - The total comprehensive income for the third quarter was CNY 42,316,316.42, compared to CNY 20,964,203.77 in the previous year, showing an increase of approximately 101.1%[36]